The certificate of analysis for Semax 10mg, lot ACE-7116313, issued by ILS Laboratories on Sep 10, 2026. Every result below is copied from the certificate as the laboratory reported it, and the document itself is further down this page.
Certificate of analysisLOT ACE-7116313
ProductSemax 10mg
LotACE-7116313
LaboratoryILS Laboratories
AccreditationISO/IEC 17025
Certificate no.COA-2026-OEIU3K
Test typeFull QC Panel
AnalysedSep 10, 2026
AppearanceGood
HPLC purity99.62%
IdentityConfirmed (HPLC-RTM)
Verify with ILS Laboratories
Opens this certificate on the laboratory’s own site.
View Semax → Every Semax COA →Results as reported
| Test | Method | Result | Specification | Status |
|---|---|---|---|---|
| Purity | HPLC | 99.62% | ≥ 95.0% | Pass |
| Net peptide content | — | 10.61 mg | — | Reported |
| Identity | HPLC-RTM | Confirmed | — | Pass |
| Fentanyl screen | — | Not Detected | — | Pass |
| Heavy metals | ICP-MS | Not Detected | — | Pass |
| Sterility | PCR | No Growth | — | Pass |
| Endotoxin | USP <85> | 0.11 EU/mL | — | Reported |
“Reported” means the certificate gives a value without a pass or fail against a limit.
The certificate
More certificates
Sold for laboratory research use only.
